| HOME >> BIOLOGY >> TECHNOLOGY |
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.
The statements in this press release regarding future events, including
statements regarding Caliper's expected revenue outlook for the fourth
quarter ending December 31, 2008, Caliper's expectations regarding its
ability to improve top-line growth and margins to accelerate its crossover
to profitability, Caliper's belief that it will achieve annualized cost
savings of approximately $2.7 million from a recently implemented
realignment of management, and Caliper's belief that its consolidation of
R&D operations will improve R&D synergies in the formation of new
technologies, are "forward-looking statements" within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended. These
statements are subject to risks and uncertainties that could cause actual
results to differ materially from those contemplated by the forward-looking
statements as a result of a number of factors, including that Caliper's
expectations regarding demand for its prod
'/>"/>
| SOURCE Caliper Life Sciences, Inc. Copyright©2008 PR Newswire. All rights reserved |